STOCK TITAN

KKR bidder (FSK) offers $150M to buy shares at $11.00 — FSK (NYSE: FSK)

(Neutral)
(Neutral)
Form Type
SC TO-T/A

Rhea-AI Filing Summary

FS KKR Capital Corp. amendment: KKR Alternative Assets L.P. filed Amendment No. 4 to its Schedule TO regarding its tender offer to purchase up to $150,000,000 in aggregate amount of common stock at a price equal to $11.00 per share, pursuant to the Offer to Purchase dated May 12, 2026. This Amendment supplements Item 11 of the Schedule TO and incorporates prior offer materials and agreements by reference, including the Offer to Purchase, Letter of Transmittal, Purchase Agreement dated May 10, 2026, and related exhibits. The Amendment is signed on behalf of KKR Alternative Assets L.P. and KKR Alternative Assets Limited and is dated June 12, 2026.

Positive

  • None.

Negative

  • None.

Insights

Legal filing updates the offer record and incorporates core agreements by reference.

The Amendment supplements Item 11 of the Schedule TO and expressly incorporates the Offer to Purchase, Letter of Transmittal, the Purchase Agreement (dated May 10, 2026), and other referenced exhibits. The Amendment names KKR Alternative Assets Limited solely because it controls the Purchaser; it does not indicate separate participation.

Material conditions and qualifiers from the Offer to Purchase remain in effect; timing and completion mechanics are governed by those underlying documents and not restated here.

Financial terms of the tender offer are reaffirmed: $150,000,000 capacity at $11.00 per share.

The Amendment confirms the offer structure: an aggregate purchase cap of $150,000,000 and a per-share purchase price of $11.00, as set forth in the Offer to Purchase dated May 12, 2026. The Amendment references the equity distribution and underwriting agreements filed by the company.

Cash‑flow treatment and the final acceptance/ proration mechanics are governed by the Offer to Purchase and Letter of Transmittal; the Amendment itself does not restate settlement details.

Tender offer cap $150,000,000 aggregate amount stated in the Offer to Purchase
Per-share price $11.00 per share price stated in the Offer to Purchase dated May 12, 2026
Offer to Purchase date May 12, 2026 date of the Offer to Purchase incorporated by reference
Purchase Agreement date May 10, 2026 Purchase Agreement between the Purchaser and the Company
Amendment signature date June 12, 2026 signature block date for Amendment No. 4
Tender Offer regulatory
"offer to purchase up to $150,000,000 in aggregate amount of shares"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Schedule TO regulatory
"Amendment No. 4 to the Schedule TO originally filed by the Purchaser on May 12, 2026"
A phrase indicating that a company plans or intends to hold an event, publish information, or take an action at a specified future time, but that the timing is not guaranteed and may change. For investors it signals an expected milestone—like an earnings call, product launch, or filing—so think of it as a calendar note rather than a firm promise; timing shifts can affect trading, expectations, and planning.
Letter of Transmittal financial
"Letter of Transmittal (including Internal Revenue Service Form W-9)"
A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.
Purchase Agreement legal
"Purchase Agreement, dated May 10, 2026, by and between the Purchaser and the Company"
A purchase agreement is a legally binding contract that spells out exactly what is being bought, for how much, and under what conditions, including timelines, seller and buyer promises, and protections if things go wrong. For investors it matters because the agreement fixes the deal’s price, risks and closing conditions—like a detailed receipt and return policy for a large transaction—so it helps determine whether the deal will complete and how it will affect the company’s value and cash flow.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the FSK Amendment No. 4 state about the tender offer size?

The Amendment reaffirmed a tender offer to purchase up to $150,000,000 in aggregate amount of common stock at $11.00 per share, as set forth in the Offer to Purchase dated May 12, 2026.

Who is making the tender offer for FSK shares?

The offer is made by KKR Alternative Assets L.P., with KKR Alternative Assets Limited named as general partner and bidder solely because it controls the Purchaser, per the Amendment text.

Which documents does the Amendment incorporate by reference for the FSK offer?

The Amendment incorporates the Offer to Purchase, Letter of Transmittal, the Purchase Agreement (May 10, 2026), and related underwriting and distribution agreements cited in Item 11.

Does Amendment No. 4 change the per‑share price or offer terms for FSK?

Amendment No. 4 supplements the Schedule TO but restates the per‑share price as $11.00 and the aggregate cap as $150,000,000; it does not introduce a different per‑share price in the disclosed text.

When was Amendment No. 4 to the Schedule TO signed for FSK?

The Amendment is signed on behalf of KKR Alternative Assets L.P. and KKR Alternative Assets Limited and is dated June 12, 2026 in the signature block.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



SCHEDULE TO
(Amendment No. 4)

Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934



FS KKR Capital Corp.
(Name of Subject Company (Issuer))

KKR Alternative Assets L.P.
KKR Alternative Assets Limited
(Name of Filing Person (Offeror))

Common stock, par value $0.001 per share
(Title of Class of Securities)

302635206
(CUSIP Number of Class of Securities)

Noah Greenhill, Esq.
KKR Alternative Assets L.P.
30 Hudson Yards
New York, NY 10001
(212) 750-8300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Persons)



Copies to:

Kenneth Wallach, Esq.
Lesley Peng, Esq.
Patrick Baron, Esq.
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, NY 10017
(212) 455-2000

 (Name, address, and telephone numbers of person authorized to receive notices and communications on behalf of filing persons)



Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

third-party tender offer subject to Rule 14d-1.

issuer tender offer subject to Rule 13e-4.

going private transaction subject to Rule 13e-3

amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer: 

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)



This Amendment No. 4 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO originally filed by KKR Alternative Assets L.P., a Delaware limited partnership (the “Purchaser”), on May 12, 2026, as amended by Amendment No. 1 filed on May 22, 2026, Amendment No. 2 filed on June 2, 2026 and Amendment No. 3 filed on June 5, 2026 (as amended, the “Schedule TO”) in connection with the Purchaser’s offer to purchase up to $150,000,000 in aggregate amount of shares of common stock, par value $0.001 per share (the “Shares”), of FS KKR Capital Corp., a Maryland corporation, at a price equal to $11.00 per share, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase dated May 12, 2026, as amended by Amendment No. 1 to the Schedule TO, Amendment No. 2 to the Schedule TO and Amendment No. 3 to the Schedule TO (the “Offer to Purchase”), which was previously filed with the Schedule TO as Exhibit (a)(1)(A), and in the related Letter of Transmittal, as amended by Amendment No. 3 to the Schedule TO (the “Letter of Transmittal”), which was previously filed with the Schedule TO as Exhibit (a)(1)(B), which, together with Amendment No. 1 to the Schedule TO, Amendment No. 2 to the Schedule TO, Amendment No. 3 to the Schedule TO and this Amendment collectively constitute the “Offer.”

KKR Alternative Assets Limited, the general partner of the Purchaser, is being named as a bidder in in this Amendment because it is deemed to control the Purchaser, but otherwise is not participating in the Offer.

Except as otherwise set forth in this Amendment, the information set forth in the Schedule TO remains unchanged and is incorporated herein by reference to the extent relevant to the Items in this Amendment. This Amendment should be read together with the Schedule TO. Capitalized terms used and not otherwise defined in this Amendment shall have the meanings assigned to such terms in the Schedule TO and the Offer to Purchase.

Item 11.
Additional Information.

The disclosure in Item 11 of the Schedule TO is hereby amended and supplemented as follows:


The Purchaser has received the preliminary results of the Offer, which expired at 11:59 p.m., New York City time, on June 11, 2026 (the “Expiration Date”).


Based on the preliminary count by Kroll Issuer Services US, the Depositary for the Offer (the “Depositary”), a total of approximately 17,993,004 Shares were validly tendered and received, and not properly withdrawn at or before the Expiration Date.


In accordance with the terms and conditions of the Offer and based on the preliminary count by the Depositary, the Purchaser expects to accept for payment, at a purchase price of $11.00 per Share, 13,636,363 Shares validly tendered and not properly withdrawn at or before the Expiration Date, at an aggregate purchase price of approximately $149,999,993, excluding fees and expenses relating to the Offer.


Since the Offer is oversubscribed, the Purchaser expects to accept the Shares on a pro rata basis and has been informed by the Depositary that the preliminary proration factor for the Offer is 75.787%.



Item 12.
Exhibits.

(a)(1)(A)
Offer to Purchase (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(a)(1)(B)
Letter of Transmittal (including Internal Revenue Service Form W-9) (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(a)(1)(C)
Press Release issued by the Purchaser on May 11, 2026 (incorporated by reference to Exhibit 99.1 to the Schedule TO-C filed by the Purchaser on May 11, 2026).
   
(a)(1)(D)
Summary Advertisement as published in The Wall Street Journal on May 12, 2026 (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(b)
None.
   
(d)(1)
Purchase Agreement, dated May 10, 2026, by and between the Purchaser and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 11, 2026).
   
(d)(2)
Form of Equity Distribution Agreement (incorporated by reference to Exhibit 10.23 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(3)
Amended and Restated Investment Advisory Agreement, dated as of June 16, 2021, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(4)
Administration Agreement, dated as of April 9, 2018, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(5)
Amendment No. 1 to Third Amended and Restated Senior Secured Revolving Credit Agreement, dated as of May 8, 2026, by and among the Company, JPMorgan Chase Bank, N.A. and each of the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 filed on May 11, 2026).
   
(d)(6)
Underwriting Agreement, dated June 1, 2026, by and among the Company, the Adviser and BofA Securities, Inc., BMO Capital Markets Corp., J.P. Morgan Securities LLC, KKR Capital Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., as representatives of the underwriters named in Schedule A thereto (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on June 2, 2026).
   
(g)
None.
   
(h)
None.




SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: June 12, 2026

KKR Alternative Assets L.P.
 
     
By: KKR Alternative Assets Limited, its general partner
 
     
By:
/s/ Noah Greenhill
 
 
Name: Noah Greenhill
 
 
Title: Authorized Signatory
 
     
KKR Alternative Assets Limited
 
     
By:
/s/ Noah Greenhill
 
 
Name: Noah Greenhill
 
 
Title: Authorized Signatory